Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy

Int J Gynaecol Obstet. 2022 Feb;156(2):236-239. doi: 10.1002/ijgo.13701. Epub 2021 May 5.

Abstract

Objective: To evaluate the incidence of occult uterine sarcomas and investigate whether an accurate and well-established preoperative assessment for uterine fibroids could help identify uterine sarcomas more effectively.

Methods: A retrospective analysis of patients who underwent gynecological laparoscopic surgery for presumed uterine fibroids at Sant'Anna Hospital, a single tertiary institute in Turin, Italy, between January 2003 and December 2019.

Results: Over the 17-year period, 5826 laparoscopic surgical procedures (myomectomies or subtotal/total hysterectomies) were performed for presumed uterine fibroids. A total of 48 patients with a final diagnosis of uterine sarcoma were identified, the majority of which (n = 39; 81.3%) were recognized as suspicious uterine sarcomas during the preoperative assessment, and morcellement was avoided. The occurrence of unexpected uterine sarcomas was 0.1% (6/5826). Morcellation was conducted in one patient with uterine sarcoma.

Conclusion: Analysis of our data showed that unexpected uterine sarcomas are uncommon. Accurate preoperative evaluation can help avoid, but does not exclude, the possibility of morcellation of unknown uterine sarcomas.

Keywords: laparoscopy; leiomyosarcoma; morcellation; ultrasound; uterine fibroids; uterine sarcomas.

MeSH terms

  • Female
  • Humans
  • Hysterectomy / adverse effects
  • Laparoscopy*
  • Leiomyoma* / epidemiology
  • Leiomyoma* / surgery
  • Leiomyosarcoma* / diagnosis
  • Leiomyosarcoma* / epidemiology
  • Leiomyosarcoma* / surgery
  • Morcellation*
  • Retrospective Studies
  • Uterine Myomectomy* / adverse effects
  • Uterine Neoplasms* / epidemiology
  • Uterine Neoplasms* / surgery